rs794728756
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_001035.3(RYR2):c.7202G>A(p.Arg2401His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R2401C) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001035.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RYR2 | NM_001035.3 | c.7202G>A | p.Arg2401His | missense_variant | 47/105 | ENST00000366574.7 | NP_001026.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RYR2 | ENST00000366574.7 | c.7202G>A | p.Arg2401His | missense_variant | 47/105 | 1 | NM_001035.3 | ENSP00000355533.2 | ||
RYR2 | ENST00000609119.2 | n.7202G>A | non_coding_transcript_exon_variant | 47/104 | 5 | ENSP00000499659.2 | ||||
RYR2 | ENST00000660292.2 | c.7202G>A | p.Arg2401His | missense_variant | 47/106 | ENSP00000499787.2 | ||||
RYR2 | ENST00000659194.3 | c.7202G>A | p.Arg2401His | missense_variant | 47/105 | ENSP00000499653.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Catecholaminergic polymorphic ventricular tachycardia 1 Pathogenic:3
Likely pathogenic, criteria provided, single submitter | clinical testing | Blueprint Genetics | Oct 19, 2015 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 16, 2021 | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RYR2 protein function. This variant has been observed in individual(s) with catecholaminergic polymorphic ventricular tachycardia (PMID: 15749201, 20851825, 28100344). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 201279). This variant is not present in population databases (ExAC no frequency). This sequence change replaces arginine with histidine at codon 2401 of the RYR2 protein (p.Arg2401His). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and histidine. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Center For Human Genetics And Laboratory Diagnostics, Dr. Klein, Dr. Rost And Colleagues | May 17, 2021 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 04, 2019 | Reported in ClinVar but additional evidence is not available (ClinVar Variant ID# 201279; Landrum et al., 2016); Not observed in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Is located in one of the three hot-spot regions of the RYR2 gene, where the majority of pathogenic missense variants occur (Medeiros-Domingo et al., 2009); A different missense change at this residue (R2401L) has been reported in the published literature in association with CPVT (Creighton et al., 2006); This variant is associated with the following publications: (PMID: 24136861, 15749201, 24025405, 19926015, 21964171, 20646679, 21616285, 25713214, 29453246, 25844899, 28449774, 30403697, 28152038, 20851825, 28100344, 31337358) - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2022 | RYR2: PM1, PM2, PM5, PS4:Moderate, PP3, PP4 - |
Cardiovascular phenotype Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 27, 2017 | The p.R2401H variant (also known as c.7202G>A), located in coding exon 47 of the RYR2 gene, results from a G to A substitution at nucleotide position 7202. The arginine at codon 2401 is replaced by histidine, an amino acid with highly similar properties. This alteration has been detected in patients with known or suspected catecholaminergic polymorphic ventricular tachycardia (CPVT) (Aizawa Y et al. Int J Cardiol. 2005;99(2):343-345; Liu J et al. Acta Cardiol Sin. 2011;27:115-119; van der Werf C et al. J Am Coll Cardiol. 2011;57:2244-54; Roston TM et al. Circ Arrhythm Electrophysiol. 2015;8:633-42). In one case, this alteration was detected in a proband with CPVT whose asymptomatic mother was reportedly mosaic (Roux-Buisson N et al. Europace. 2011;13:130-2). This alteration was reported as occuring de novo in an 8-year-old drowning victim, and in a patient with reported CPVT (Tester DJ et al. Mayo Clin Proc. 2011;86:941-7; Liu X et al. Zhonghua Xin Xue Guan Bing Za Zhi. 2017;45:39-43). Another alteration affecting this amino acid (p.R2401L) was detected in a 12-year-old boy with sudden death (Creighton W et al. J Mol Diagn. 2006;8:62-7). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at